These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2940474)

  • 1. Positron emission tomography in the early diagnosis of Huntington's disease.
    Hayden MR; Martin WR; Stoessl AJ; Clark C; Hollenberg S; Adam MJ; Ammann W; Harrop R; Rogers J; Ruth T
    Neurology; 1986 Jul; 36(7):888-94. PubMed ID: 2940474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan.
    Kuhl DE; Phelps ME; Markham CH; Metter EJ; Riege WH; Winter J
    Ann Neurol; 1982 Nov; 12(5):425-34. PubMed ID: 6217782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal caudate glucose metabolism in persons at risk for Huntington's disease.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel D; Berent S; Rothley J; Betley A; Hichwa R
    Arch Neurol; 1987 Mar; 44(3):254-7. PubMed ID: 2950844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of cerebral glucose utilization in Parkinson's disease and Huntington's disease.
    Kuhl DE; Metter EJ; Riege WH; Markham CH
    Ann Neurol; 1984; 15 Suppl():S119-25. PubMed ID: 6234856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional caudate imaging in symptomatic Huntington's disease: positron emission tomography versus single-photon emission computed tomography.
    Martin WR; Hoskinson M; Kremer B; Maguire C; McEwan A
    J Neuroimaging; 1995 Oct; 5(4):227-32. PubMed ID: 7579751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington's disease.
    Antonini A; Leenders KL; Spiegel R; Meier D; Vontobel P; Weigell-Weber M; Sanchez-Pernaute R; de Yébenez JG; Boesiger P; Weindl A; Maguire RP
    Brain; 1996 Dec; 119 ( Pt 6)():2085-95. PubMed ID: 9010012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local cerebral glucose utilization in symptomatic and presymptomatic Huntington's disease.
    Kuhl DE; Markham CH; Metter EJ; Riege WH; Phelps ME; Mazziotta JC
    Res Publ Assoc Res Nerv Ment Dis; 1985; 63():199-209. PubMed ID: 3161165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal glucose consumption in chorea-free subjects at risk of Huntington's disease.
    Kuwert T; Lange HW; Boecker H; Titz H; Herzog H; Aulich A; Wang BC; Nayak U; Feinendegen LE
    J Neurol; 1993 Nov; 241(1):31-6. PubMed ID: 8138819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral metabolism of glucose in benign hereditary chorea.
    Suchowersky O; Hayden MR; Martin WR; Stoessl AJ; Hildebrand AM; Pate BD
    Mov Disord; 1986; 1(1):33-44. PubMed ID: 2973557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
    López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain glucose utilization in childhood Huntington's disease studied with positron emission tomography (PET).
    De Volder A; Bol A; Michel C; Cogneau M; Evrard P; Lyon G; Goffinet AM
    Brain Dev; 1988; 10(1):47-50. PubMed ID: 2967038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease.
    Mazziotta JC; Phelps ME; Pahl JJ; Huang SC; Baxter LR; Riege WH; Hoffman JM; Kuhl DE; Lanto AB; Wapenski JA
    N Engl J Med; 1987 Feb; 316(7):357-62. PubMed ID: 2949152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington's disease.
    Kuwert T; Noth J; Scholz D; Schwarz M; Lange HW; Töpper R; Herzog H; Aulich A; Feinendegen LE
    Mov Disord; 1993; 8(1):98-106. PubMed ID: 8419813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FDG/PET methodology for early detection of disease onset: a statistical model.
    Clark CM; Ammann W; Martin WR; Ty P; Hayden MR
    J Cereb Blood Flow Metab; 1991 Mar; 11(2):A96-102. PubMed ID: 1825496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A primate model of Huntington's disease: functional neural transplantation and CT-guided stereotactic procedures.
    Schumacher JM; Hantraye P; Brownell AL; Riche D; Madras BK; Davenport PD; Maziere M; Elmaleh DR; Brownell GL; Isacson O
    Cell Transplant; 1992; 1(4):313-22. PubMed ID: 1344304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline.
    Young AB; Penney JB; Starosta-Rubinstein S; Markel DS; Berent S; Giordani B; Ehrenkaufer R; Jewett D; Hichwa R
    Ann Neurol; 1986 Sep; 20(3):296-303. PubMed ID: 2945510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Arch Neurol; 1992 Nov; 49(11):1161-7. PubMed ID: 1444883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG(33) repeat length in the Huntington's disease gene.
    Squitieri F; Esmaeilzadeh M; Ciarmiello A; Jankovic J
    Mov Disord; 2011 Apr; 26(5):925-7. PubMed ID: 21370274
    [No Abstract]   [Full Text] [Related]  

  • 20. Positron emission tomography imaging of regional cerebral glucose metabolism.
    Alavi A; Dann R; Chawluk J; Alavi J; Kushner M; Reivich M
    Semin Nucl Med; 1986 Jan; 16(1):2-34. PubMed ID: 2935938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.